Options Wonderland

[langlui]

ups and downs 3-11

Read more: http://www.briefing.com/Platinum/InDepth/InPlay.htm#ixzz2NEsoHBUr

09:29 INO Inovio Pharma initiated with a Buy at Aegis Capital; tgt $1.50 (0.54 )
Aegis Capital initiates INO with a Buy and price target of $1.50. In our view, Inovio is a highly diversified developer of differentiated DNA-based vaccines, which could represent novel and highly effective ways to treat various inflammatory, oncology-focused and infectious disorders.

Read more: http://www.briefing.com/Platinum/InDepth/InPlay.htm#ixzz2NErR8oUO
Under Creative Commons License: Attribution
Follow us: @Briefingcom on Twitter | Briefingcom on Facebook

08:17 SUMRX Gapping up/down: GNW +9.3%, ELN +5.6% ... DKS -5.8% following earnings/guidance, AAPL -0.6%
Gapping up:
M&A related: SCR +13.7% (Simcere Pharmaceutical Group announces receipt of 'Going Private' proposal; the Buyer Group proposes to acquire outstanding ordinary shares not currently owned for $9.56 per ADS or $4.78 per ordinary shares in cash).

Other news: GNW +9.3% (positive mention in Barron's), CIM +6.5% (higher after filing 2011 annual report on Form 10-K and restating prior periods), KWK +6.1% (disclosed Amended and Restated Rights Agreement between Quicksilver Resources Inc. and Computershare Shareowner Services), ELN +5.6% (Elan provides update on Tysabri transaction and $1 bln share repurchase: U.S. and EU regulatory closing conditions satisfied), HIMX +4.3% (continued strength), ERIC +1.4% (ST-Ericsson announced change in executive management).

Analyst comments: BBY +2.4% (upgraded to Overweight from Neutral at Piper Jaffray), C +0.7% (upgraded to Buy from Neutral at UBS)

Gapping down:
In reaction to disappointing earnings/guidance: DKS -5.8%, CSIQ -5.6% (ticking lower).

Select financial related names showing weakness: NBG -9.5%, RBS -3.0%, BCS -2.9%, LYG -2.3%, SAN -1.8%, HBC -0.6%.

Other news: CYS -2.2% (declares Q1 dividend of $0.32 vs. $0.40 last quarter), NOK -2.2% (still checking for anything specific), UA -1.5% and NKE -1.3% (ticking lower following DKS results).

Analyst comments: ERII -5.9% (light volume, downgraded to Underperform from Neutral at Wedbush), VE -2.3% (downgraded to Neutral from Buy at Goldman), NVDA -0.9% (NVIDIA downgraded to Negative from Neutral at Susquehanna), ALTR -0.7% (downgraded to Neutral from Buy at UBS), AAPL -0.6% (downgraded to Outperform from Buy at Credit Agricole)